Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis

Chemotherapy-induced hemorrhagic cystitis (CHC) can be difficult to manage. Prior work suggests IL-4 alleviates ifosfamide-induced hemorrhagic cystitis (IHC), but systemically administered IL-4 causes significant side effects. We hypothesized that the Schistosoma haematobium homolog of Interleukin-4...

Full description

Bibliographic Details
Main Authors: Mbanefo, Evaristus C., Le, Loc, Pennington, Luke F., Odegaard, Justin I., Jardetzky, Theodore S., Alouffi, Abdulaziz, Falcone, Franco H., Hsieh, Michael H.
Format: Article
Language:English
Published: Federation of American Society of Experimental Biology 2018
Subjects:
Online Access:https://eprints.nottingham.ac.uk/50318/
_version_ 1848798218470555648
author Mbanefo, Evaristus C.
Le, Loc
Pennington, Luke F.
Odegaard, Justin I.
Jardetzky, Theodore S.
Alouffi, Abdulaziz
Falcone, Franco H.
Hsieh, Michael H.
author_facet Mbanefo, Evaristus C.
Le, Loc
Pennington, Luke F.
Odegaard, Justin I.
Jardetzky, Theodore S.
Alouffi, Abdulaziz
Falcone, Franco H.
Hsieh, Michael H.
author_sort Mbanefo, Evaristus C.
building Nottingham Research Data Repository
collection Online Access
description Chemotherapy-induced hemorrhagic cystitis (CHC) can be difficult to manage. Prior work suggests IL-4 alleviates ifosfamide-induced hemorrhagic cystitis (IHC), but systemically administered IL-4 causes significant side effects. We hypothesized that the Schistosoma haematobium homolog of Interleukin-4-inducing principle from Schistosoma mansoni Eggs (H-IPSE), would reduce IHC and associated bladder pathology. IPSE binds IgE on basophils and mast cells, triggering IL-4 secretion by these cells. IPSE is also an “infiltrin”, translocating into the host nucleus to modulate gene transcription. Mice were administered IL-4, H-IPSE protein or its nuclear localization sequence (NLS) mutant with or without neutralizing anti-IL-4 antibody, or MESNA, followed by ifosfamide. Bladder tissue damage and hemoglobin content were measured. Spontaneous and evoked pain, urinary frequency and gene expression were assessed. Pain behaviors were interpreted in a blinded fashion. One dose of H-IPSE was superior to MESNA and IL-4 in suppressing bladder hemorrhage in an IL-4-and NLS-dependent fashion, and comparable to MESNA in dampening ifosfamide-triggered pain behaviors in an NLS-dependent manner. H-IPSE also accelerated urothelial repair following IHC. Our work represents the first therapeutic exploitation of a uropathogen-derived host modulatory molecule in a clinically relevant bladder disease model, and indicates that IPSE may be an alternative to MESNA for mitigating CHC.
first_indexed 2025-11-14T20:16:17Z
format Article
id nottingham-50318
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T20:16:17Z
publishDate 2018
publisher Federation of American Society of Experimental Biology
recordtype eprints
repository_type Digital Repository
spelling nottingham-503182018-09-27T10:23:58Z https://eprints.nottingham.ac.uk/50318/ Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis Mbanefo, Evaristus C. Le, Loc Pennington, Luke F. Odegaard, Justin I. Jardetzky, Theodore S. Alouffi, Abdulaziz Falcone, Franco H. Hsieh, Michael H. Chemotherapy-induced hemorrhagic cystitis (CHC) can be difficult to manage. Prior work suggests IL-4 alleviates ifosfamide-induced hemorrhagic cystitis (IHC), but systemically administered IL-4 causes significant side effects. We hypothesized that the Schistosoma haematobium homolog of Interleukin-4-inducing principle from Schistosoma mansoni Eggs (H-IPSE), would reduce IHC and associated bladder pathology. IPSE binds IgE on basophils and mast cells, triggering IL-4 secretion by these cells. IPSE is also an “infiltrin”, translocating into the host nucleus to modulate gene transcription. Mice were administered IL-4, H-IPSE protein or its nuclear localization sequence (NLS) mutant with or without neutralizing anti-IL-4 antibody, or MESNA, followed by ifosfamide. Bladder tissue damage and hemoglobin content were measured. Spontaneous and evoked pain, urinary frequency and gene expression were assessed. Pain behaviors were interpreted in a blinded fashion. One dose of H-IPSE was superior to MESNA and IL-4 in suppressing bladder hemorrhage in an IL-4-and NLS-dependent fashion, and comparable to MESNA in dampening ifosfamide-triggered pain behaviors in an NLS-dependent manner. H-IPSE also accelerated urothelial repair following IHC. Our work represents the first therapeutic exploitation of a uropathogen-derived host modulatory molecule in a clinically relevant bladder disease model, and indicates that IPSE may be an alternative to MESNA for mitigating CHC. Federation of American Society of Experimental Biology 2018 Article PeerReviewed application/pdf en cc_by https://eprints.nottingham.ac.uk/50318/1/fj.201701415r.pdf Mbanefo, Evaristus C., Le, Loc, Pennington, Luke F., Odegaard, Justin I., Jardetzky, Theodore S., Alouffi, Abdulaziz, Falcone, Franco H. and Hsieh, Michael H. (2018) Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis. FASEB Journal, 32 (8). pp. 4408-4419. ISSN 1530-6860 Infiltrin; Anti-inflammation; Ifosfamide; Allodynia; Urothelial repair https://www.fasebj.org/doi/10.1096/fj.201701415R doi:10.1096/fj.201701415R doi:10.1096/fj.201701415R
spellingShingle Infiltrin; Anti-inflammation; Ifosfamide; Allodynia; Urothelial repair
Mbanefo, Evaristus C.
Le, Loc
Pennington, Luke F.
Odegaard, Justin I.
Jardetzky, Theodore S.
Alouffi, Abdulaziz
Falcone, Franco H.
Hsieh, Michael H.
Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis
title Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis
title_full Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis
title_fullStr Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis
title_full_unstemmed Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis
title_short Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis
title_sort therapeutic exploitation of ipse, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis
topic Infiltrin; Anti-inflammation; Ifosfamide; Allodynia; Urothelial repair
url https://eprints.nottingham.ac.uk/50318/
https://eprints.nottingham.ac.uk/50318/
https://eprints.nottingham.ac.uk/50318/